Leukemia Research
Volume 30, Issue 4 , Pages 407-413 , April 2006

Combination of tetrandrine as a potential-reversing agent with daunorubicin, etoposide and cytarabine for the treatment of refractory and relapsed acute myelogenous leukemia

  • Wen-Lin Xu

      Affiliations

    • Department of Hematology, The Affiliated People's Hospital, Jiangsu University, 8 Dianli Road, Zhenjiang 212002, PR China
    • Corresponding Author InformationCorresponding author. Tel.: +86 511 5246930; fax: +86 511 5234387.
    • ,
  • Hui-Ling Shen

      Affiliations

    • Department of Hematology, The Affiliated People's Hospital, Jiangsu University, 8 Dianli Road, Zhenjiang 212002, PR China
    • ,
  • Zhong-Fang Ao

      Affiliations

    • Department of Hematology, The First Affiliated Hospital, Nanjing Medical University, Nanjing 210029, PR China
    • ,
  • Bao-An Chen

      Affiliations

    • Department of Hematology, The Affiliated Zhong-Da Hospital, Southeast University, Nanjing 210009, PR China
    • ,
  • Wei Xia

      Affiliations

    • Department of Hematology, The First Affiliated Hospital, Nanjing Medical University, Nanjing 210029, PR China
    • ,
  • Feng Gao

      Affiliations

    • Department of Hematology, The Affiliated Zhong-Da Hospital, Southeast University, Nanjing 210009, PR China
    • ,
  • Yong-Ning Zhang

      Affiliations

    • Department of Hematology, The Affiliated People's Hospital, Jiangsu University, 8 Dianli Road, Zhenjiang 212002, PR China

Received 26 May 2005 ,Accepted 8 August 2005.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0145-2126(05)00313-9

doi: 10.1016/j.leukres.2005.08.005

Leukemia Research
Volume 30, Issue 4 , Pages 407-413 , April 2006

Article Tools

* Image Usage & Resolution